Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Indivior Pharmaceuticals (INDV) Other Non Operating Income (2022 - 2023)

Historic Other Non Operating Income for Indivior Pharmaceuticals (INDV) over the last 2 years, with Q3 2023 value amounting to -$13.0 million.

  • Indivior Pharmaceuticals' Other Non Operating Income rose 1875.0% to -$13.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$24.0 million, marking a year-over-year change of. This contributed to the annual value of $1.0 million for FY2022, which is N/A changed from last year.
  • Indivior Pharmaceuticals' Other Non Operating Income amounted to -$13.0 million in Q3 2023, which was up 1875.0% from $4.0 million recorded in Q2 2023.
  • Indivior Pharmaceuticals' Other Non Operating Income's 5-year high stood at $4.0 million during Q2 2023, with a 5-year trough of -$16.0 million in Q3 2022.